Clinical Trials in Longmont, United States
Locations / Longmont, United States
Delta Trials lists 590 clinical trials conducted in Longmont, United States, making it a notable site of clinical research activity. These trials addressing 1,494 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 47 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Longmont research landscape.
590
Total Trials
1494
Conditions
47
Terminated since 2020
Browse by condition (1494 total)
- Breast cancer 35 trialsAll Breast cancer trials
- All Unspecified adult solid tumor, protocol specific trials
- Lymphoma 13 trialsAll Lymphoma trials
- Lung cancer 12 trialsAll Lung cancer trials
- Recurrent breast carcinoma 12 trialsAll Recurrent breast carcinoma trials
- Leukemia 11 trialsAll Leukemia trials
- Recurrent squamous cell lung carcinoma 10 trialsAll Recurrent squamous cell lung carcinoma trials
- Colorectal cancer 9 trialsAll Colorectal cancer trials
- Invasive breast carcinoma 9 trialsAll Invasive breast carcinoma trials
- Prostate cancer 9 trialsAll Prostate cancer trials
- Multiple myeloma 9 trialsAll Multiple myeloma trials
- Stage iv lung cancer ajcc v8 9 trialsAll Stage iv lung cancer ajcc v8 trials
- Recurrent ovarian carcinoma 8 trialsAll Recurrent ovarian carcinoma trials
- Influenza 8 trialsAll Influenza trials
- All Stage iv breast cancer ajcc v6 and v7 trials
- Fatigue 8 trialsAll Fatigue trials
- All Stage iv squamous cell lung carcinoma ajcc v7 trials
- All Recurrent lung non-small cell carcinoma trials
- Malignant solid neoplasm 7 trialsAll Malignant solid neoplasm trials
- Recurrent melanoma 7 trialsAll Recurrent melanoma trials